Coming Tuesday, March 2, 2022
University of Wisconsin Carbone Cancer Center Research Retreat
“Theranostics and Tumor Microenvironment”
Co-Chairs of the Event are Suzanne Ponik, PhD and Reinier Hernandez, PhD
We would love to hear what you think!
Click the button below to take our post event survey.
Research Retreat 2022: "Theranostics and Tumor Microenvironment"
This year the Carbone Cancer Center Research Retreat will focus on Theranostics and Tumor Microenvironment. The in-person event allows us to come together to engage, share research visions, and learn from each other.
The contributions from each individual to our Carbone Cancer Center team—from trainees, to administrators, researchers, clinicians and faculty — allow us to move forward together and be the driving force for research, prevention, and treatment initiatives critical to defeating cancer in Wisconsin and around the world.
Hear from our Keynote Speakers
Johanna Joyce, PhD,
“Exploring and Therapeutically Exploiting the Tumor Microenvironment”
Johanna Joyce is a Professor at the University of Lausanne, Switzerland, and Full Member of the international Ludwig Institute for Cancer Research. Johanna’s lab investigates the microenvironment in which a tumor arises and the critical influence that non-cancerous immune and stromal cells can have on tumor progression, metastasis and therapeutic response. They have uncovered critical regulatory signals provided by the normal tissue stroma and immune cells to the cancer cells and determined how these normal cells can be modified by the cancer cells to produce a plethora of factors that enhance tumor malignancy. A major focus of her lab’s recent research has been to deeply and comprehensively interrogate the immune landscape of brain tumors, and then use this gained knowledge to develop novel strategies to therapeutically target the tumor microenvironment.
Michael Morris, MD
“The Past, Present, and Future of Intertwining Tumor and Microenvironment Targeting in Prostate Cancer”
Dr. Michael Morris is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. Much of Dr. Morris’ research focuses on drugs that can deliver radioactive molecules targeted specifically to prostate cancer cells or to the distant areas where the cancer spreads. These drugs can be used alone or in combination with other anti-cancer strategies. This research represents a team effort between medical oncologists, nuclear medicine doctors, and radiologists to bring these novel and exciting drugs to the people with prostate cancer who need them.
Agenda
This is an accordion element with a series of buttons that open and close related content panels.
Welcome and Keynote
Welcome and Introductions: Dr. Howard Bailey
11:00 am – 12:00 pm Keynote Speaker: Johanna Joyce, PhD
12:00 pm – 1:00 pm Lunch Break
1:00 pm – 2:00 pm Keynote Speaker: Michael Morris, MD
2:00 pm – 3:00 pm Breakout Sessions
3:00 pm – 3:15 pm Break
3:15 pm – 4:15 pm Trainee Presentations
4:15 pm – 5:15 pm Poster Session and Reception
Click here to join. Password:
Breakout Sessions
Breakout Session #1: “Highlights from New UWCCC Members” Dr. Kratz, Dr. Lang, Dr. Mendez, and Dr. LeBeau
Breakout Session #2: “A Scientist’s Guide to Science Communication” Dr. Zinnen and Dr. Duma
Zoom Registration Register first and then join Zoom via the emailed link.
Trainee Presentations (In-Person ONLY**)
Selected trainees will have the opportunity to present their work to an audience.
- Debayan De Bakshi: CH60 complexes with TLR4 at the cell surface to mediate bortezomib resistance in multiple myeloma.
- Jenna Hansen: Psychological and Physical Function in Hematopoietic Cell Transplant Patients with Chronic Graft-Versus-Host Disease
- Kourtney Kostecki: Simultaneous inhibition of Axl and MerTK enhances anti-PDL1 efficacy and creates a proinflammatory tumor immune microenvironment in head and neck cancer
- David Komjathy: Immune Checkpoint Inhibition and Epigenetic Regulation to Enhance Neuroblastoma Responses
- Shirsa Udgata: Patient derived cancer organoids predict clinical response for patients with locally advanced rectal cancer
- Zoe Walts: Anthropometric Obesity Measurements and Colorectal Cancer (CRC) Risk in the Southern Community Cohort Study (SCCS)
**In-person session only. Recording available at a later date.
Poster Session & Reception (In-person Only)
The Poster Session will highlight the work of trainees and lab researchers. The session will take place from 4:15 pm – 5:15 pm in the Health Learning Sciences Center Atrium. Trainees and researchers will be available to share their research and answer any questions you may have regarding their work.
Poster Presentation Categories and Abstracts (Abstract Book Link)
Poster Category 1: Tumor Treatment and Strategies
Poster Category 2: Cancer Immunotherapy
Poster Category 3: Drug Development and Theranostics
Poster Category 4: Single Cell Analyses/Omics
Poster Category 5: Molecular Oncology
Poster Category 6: Tumor Microenvironment
Poster Category 7: Detection, Biomarkers, and Prediction Models
Poster Category 8: Mechanisms of Therapy Resistance
Poster Category 9: Population Health
Congratulations to the 2022 Research Retreat Trainee Award Winners
1st Place
Kourtney Kostecki
“Simultaneous inhibition of Axl aabd MerTK enhances anti-PDL1 efficacy and creates a proinflammatory tumor immune microenvironment in head and neck cancer.”
2nd Place
Shirsa Udgata
“Patient derived cancer organoids predict clinical response for patients with locally advanced rectal cancer”
3rd Place
Jenna Hansen
“Psychological and Physical Function in Hematopoietic Cell Transplant Patients with Chronic Graft-Versus-Host Disease”